Helping patients reclaim a life of possibility
We are delighted to share MPE’s Year in Review 2025, a summary of what we have achieved this year alongside our many collaborators. This year we have strengthened partnerships, welcomed new members into our community and made progress on the European advocacy issues that matter most to patients and their families. We have worked together…
On 15 November, MPE member organisation AF3M (the French Association of Myeloma Patients) held its 20th National Myeloma Day across 28 cities in France, including La Réunion Island. This remarkable milestone event brought together patients and carers for information and discussion, organised in collaboration with AF3M’s longstanding partner IFM (Intergroupe Francophone du Myélome), whose research…
Despite war-related damage to its original venue, MPE member organisation AMEN Israel brought together leading haematologists and patients to explore pathways to curing myeloma in a memorable 20th anniversary conference. AMEN Israel, MPE’s member organisation in Israel and the country’s myeloma patient association, marked a significant milestone this year with its 20th anniversary conference. What…
On Saturday, 18 October, a regional meeting of patients, doctors, associations, and institutional representatives from Bosnia and Herzegovina, Croatia, and Serbia was held in Sarajevo, under the title “Together for Life with Myeloma” – Myeloma Day 2025, organised by Mijelom u BiH, (the Association of Patients with Multiple Myeloma, Myelodysplastic Syndrome, and Other Rare Blood Diseases…
This September, our Slovenian member organisation, Društvo BKB, once again marked Blood Cancer Awareness Month and European Myeloma Day, with a wide range of activities dedicated to raising awareness and supporting patients across Slovenia. They organised 12 information stands in health centres, hospitals, and at the University Medical Centres in Ljubljana and Maribor. A special…
Throughout September, the Multiple Myeloma Patient Association of Serbia (MMPAS) marked Blood Cancer Awareness Month with a powerful and heartfelt series of activities across the country — especially in smaller towns, where awareness of multiple myeloma remains extremely low. Guided by empathy and driven by purpose, they launched two national campaigns focused on informing, educating,…
How are costs and medicine effectiveness part of decision-making in medicine access? Thursday, 9 October 2025, 17:00 – 18:30 CET Aimed at patients, carers and patient advocates, as well as to a general audience, the webinar will provide basic knowledge on the topic of cost-effectiveness analysis in decision-making (including health technology assessment) on new medicines.…
Myeloma is a form of blood cancer. At diagnosis, and at each relapse, myeloma patients are confronted with complex treatment and care decisions that may feel overwhelming. What are my options? What are the side effects? How will it affect my quality of life? The questions you have regarding your care choices are deeply personal…